Matthew Bernard , PhD

Biography

Matthew Bernard is an Associate Professor in the Department of Pharmacology & Toxicology at Michigan State University. He joined MSU from Bristol-Myers Squibb where he worked as a Senior Research Investigator in Drug Safety Evaluation, performing investigative Immunotoxicology research on small molecules and Biologics. Dr. Bernard is currently the Director of the Research Technology Support Facility at Michigan State University, a collective of Cores broadly supporting research on campus. Dr. Bernard obtained his B.S. in Biochemistry at the State University of New York (SUNY) Geneseo. He obtained his Ph.D. in Microbiology & Immunology at the University of Rochester School of Medicine & Dentistry and subsequently worked as a postdoctoral fellow at the La Jolla Institute for Allergy & Immunology (LIAI). He has broad knowledge in designing and conducting applied research studies in Immunopharmacology and Immunotoxicology in a GLP environment. Dr. Bernard has specialized in immunoassay development, validation, and implementation for pharmacology and toxicology endpoints, including having over 20 years of flow cytometry experience. He has extensive experience developing flow cytometric assays and applications, including validating immunophenotyping panels, pharmacodynamic assessments, receptor occupancy evaluation, as well as assays to assess intracellular cytokines, phosphorylated protein expression, transcription factor, proliferation, cell cycle, and viability.